Pre-treatment Pain Symptoms Influence Antidepressant Response to Ketamine in Depressive Patients

Bibliographic Data

ID15518477
AuthorsXiaofeng Lan (0000-0002-7042-084X, Guangzhou Medical University), Yanling Zhou (0000-0002-3966-4424, Guangzhou Medical University), Chengyu Wang (0000-0003-0516-332X, Guangzhou Medical University), Weicheng Li (0000-0001-9880-9390, Guangzhou Medical University), Fan Zhang (0000-0002-3643-018X, Guangzhou Medical University), Haiyan Liu (0000-0002-3812-7520, Guangzhou Medical University), Ling Fu (0000-0002-7017-6242, Guangzhou Medical University), Kai Wu (0000-0003-4684-9758, Guangzhou Medical University), Roger S McIntyre (0000-0003-4733-2523, Brain and Cognition Discovery Foundation, corresponding author), Yuping Ning (0000-0002-5727-2782, Southern Medical University, corresponding author)
Year2022
Volume13
Pages793677-793677
Publication date2022-03-16
Open AccessYes
TypeARTICLE
VenueFrontiers in Psychiatry (JOURNAL)
Journal identifiersISSN: 1664-0640 • E-ISSN: 1664-0640
PublisherFrontiers Media (PUBLISHER • CH)
DOI10.3389/fpsyt.2022.793677
PMID35370832
OpenAlexW4220892104
LanguageEN
References cited46

A significant and rapid improvement in depressive symptoms was observed in patients with depression and pain after ketamine treatment. Ketamine may be a novel and promising antidepressant preferentially for the therapy of depression with severe pain

Analgesic · Anesthesia · Antidepressant · Depression (economics · Ketamine · Major depressive disorder · Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes · Medicine · Treatment of Major Depression · Tryptophan and brain disorders · Internal Medicine

Tools

Open DOIOpen Access